← FDA DRUG APPROVALS

FDA NDA · NDA019712

AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER

Sponsor: ABBOTT

APPLICATION
NDA019712
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, DEXTROSE 10GM/100ML, MAGNESIUM CHLORIDE 51MG/100ML, POTASSIUM ACETATE 176.5MG/100ML, POTASSIUM CHLORIDE 22.4MG/100ML, POTASSIUM PHOSPHATE, DIBASIC 104.5MG/100ML, SODIUM CHLORIDE 205MG/100ML · INJECTABLE · INJECTION
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 3.5%, DEXTROSE 5GM/100ML, MAGNESIUM CHLORIDE 30MG/100ML, POTASSIUM CHLORIDE 97MG/100ML, SODIUM CHLORIDE 120MG/100ML, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 49.3MG/100ML · INJECTABLE · INJECTION
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →